비즈니스 · 2010. 2. 24.1 분 읽기
Pulmonary-Allergy Drugs Advisory Committee; Amendment of Notice
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Pulmonary-Allergy Drugs Advisory Committee. This meeting was announced in the Federal Register of February 2, 2010 (75 FR 5334). The amendment is being made to reflect a change in the Name of Committee portion of the document. There are no other changes.